Moderna
MRNA
#1230
Rank
ยฃ11.67 B
Marketcap
ยฃ30.35
Share price
3.55%
Change (1 day)
-51.92%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total assets

Total assets on the balance sheet as of September 2024 : ยฃ12.53 Billion

According to Moderna 's latest financial reports the company's total assets are ยฃ12.53 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Moderna - Total assets on balance sheet (from 2017 to 2024)

Total assets by year

Year Total assets Change
2023-12-31ยฃ14.46 B-32.33%
2022-12-31ยฃ21.37 B16.95%
2021-12-31ยฃ18.27 B239.52%
2020-12-31ยฃ5.38 B344.08%
2019-12-31ยฃ1.21 B-21.59%
2018-12-31ยฃ1.54 B92.64%
2017-12-31ยฃ0.80 B-30.13%
2016-12-31ยฃ1.14 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
ยฃ82.61 M-99.34%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ93.25 B 643.73%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ5.89 M-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ3.33 B-73.39%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ82.14 B 555.09%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
ยฃ0.70 B-94.41%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ141.46 B 1,028.18%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA